...
...
Next Story

Serum Institute to produce up to 100 million Covid-19 vaccine doses priced at Rs 225

The Bill & Melinda Gates Foundation, via its Strategic Investment Fund, will provide at-risk funding of $150 million to Gavi, which will be used to support the SII to manufacture the potential Covid-19 vaccine candidates.

Updated on: Aug 8, 2020, 14:54:33 IST
Advertisement

Serum Institute of India (SII) on Friday said it has entered into a new partnership with international vaccine alliance Gavi and Bill & Melinda Gates Foundation to accelerate manufacturing and delivery of up to 100 million doses of Covid-19 vaccines for India as well as other low and middle-income countries (LMICs).

Vaccine vials exit a vaccine vial monitor labelling machine at the Serum Institute of India Ltd. pharmaceutical plant in Pune. (Bloomberg File Photo)
Vaccine vials exit a vaccine vial monitor labelling machine at the Serum Institute of India Ltd. pharmaceutical plant in Pune. (Bloomberg File Photo)

“The collaboration will provide upfront capital to SII to help them increase manufacturing capacity now so that, once a vaccine, or vaccines, gains regulatory approval and WHO prequalification, doses can be produced at scale for distribution to India and LMICs as part of the Gavi COVAX AMC mechanism as early as the first half of 2021,” SII said in a statement. The company has set an affordable ceiling price of $3 (around Rs 225) per dose, it added.

Follow latest updates on coronavirus here

The funding will support at-risk manufacturing by SII for candidate vaccines from AstraZeneca and Novavax, which will be available for procurement if they are successful in attaining full licensure and WHO prequalification, the statement said.

Click here for complete coronavirus coverage

Through this association, SII seeks to ramp up constant efforts to save the lives of millions of people from this dreadful disease, he added. Serum Institute has a long history of partnerships with Gavi and pharmaceutical companies to manufacture vaccines that protect against meningitis, severe diarrhoea, pneumonia and measles, the statement said.

“We are very happy to see SII enter this global partnership to respond to the global health crisis posed by COVID-19,” Renu Swarup, secretary in the Department of Biotechnology, Government of India, said.

India has a proven track record of manufacturing safe and cost-effective vaccines not only for India, but for the world, she added. In a similar vein, Indian Council of Medical Research Director General Balram Bhargava said: “ICMR is deeply supportive of our cutting edge vaccine research and manufacturing prowess, of which SII is one prominent example. This partnership signifies yet another step in India’s efforts to bolster the fight against this global pandemic.” Vaccines will be priced at maximum $3 per dose and made available to the 92 countries included in Gavi’s COVAX AMC, it added.

 
ABOUT THE AUTHOR
HT News Desk

Follow the latest breaking news, major developments and agenda-setting stories from India and around the world with the newsdesk at Hindustan Times. Operating round the clock, the desk brings together experienced editors, reporters and correspondents to deliver fast, accurate and contextual reporting across subjects that influence public policy, governance, business, society and international affairs. The HT News Desk covers politics, elections, government policies, the economy, business and markets, science and technology, the environment, law and order, infrastructure, education, climate issues and geopolitics, while closely tracking developments across states, institutions and global capitals. The team also leads coverage of major breaking news events, policy announcements, court proceedings, natural disasters, public emergencies and significant international developments. Reports published by the newsdesk are based on information gathered from reporters on the ground, official statements, government agencies, court records, regulatory filings, recognised institutions and other authoritative sources. Stories undergo editorial scrutiny and verification processes to ensure accuracy, fairness and relevance, and are updated as events evolve and additional information becomes available. Whether covering a key political decision in New Delhi, an economic policy shift affecting millions, a landmark court ruling or a major global event, the HT News Desk aims to provide readers with reliable, fact-based journalism that delivers not only the latest developments but also the context and analysis needed to understand their wider implications.

Get Latest News, breaking headlines, and top India News, and today real-time updates from across the nation. Stay informed on politics, government policies, crime, Today Weather, and major developments on Hindustan Times
Get Latest News, breaking headlines, and top India News, and today real-time updates from across the nation. Stay informed on politics, government policies, crime, Today Weather, and major developments on Hindustan Times
SHARE THIS ARTICLE ON
Notifications

Get breaking alerts directly from the newsroom

Notifications are on!You'll be notified when news breaks